Search Results

Olink Holding AB announced that Novogene Asia Pacific Middle East and Africa has adopted the Olink Explore HT platform to deliver advanced next-generation proteomics technology to the scientific community in the region.

Novogene at the forefront of cutting-edge next-generation sequencing (NGS) services, has officially announced Falcon II, a superpowered robot scientist for autonomously intelligent NGS delivery.

Novogene’s global customers will now have a high-throughput solution for long-read genome analysis enabling clinical-grade structural variation discovery and platinum genome assembly

Chipscreen Biosciences Co., Ltd. and Novogene Co., Ltd. recently announced a strategic partnership for companion diagnostics development.

High-throughput sequencing methods mainly bases on Illumina platforms have benefited the entire field of biology for more than a decade.

High-throughput sequencing methods mainly based on Illumina platforms have benefited the entire field of biology for more than a decade.

LifeMap Sciences, Inc., a subsidiary of AgeX Therapeutics, Inc. (NYSE American: AGE) announced today that Tianjin Novogene Medical Laboratory, LifeMap, and Shanghai Shanyi today announced a partnership to provide a combined, best-of-breed Clinical NGS analysis and interpretation platform for Tianjin Novogene Medical Laboratory’s customers in China.

Partnership will enhance biomarker-driven patient enrollment in clinical trials of Hummingbird Bioscience’s lead program, HMBD-001

New platform drives industry forward and opens up a new era for NGS technology